Clinical trial
Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar…
NCT00374543 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00374543 |
|---|---|
| Title | Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder |
| Official title | Ziprasidone for the Treatment of Generalized Anxiety Comorbidity in Patients With Bipolar Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Generalized Anxiety Disorder, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Ziprasidone, Placebo |
| Enrollment | 3 |
| Start date | Feb 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Sep 11, 2006 |
| Last update posted | Apr 16, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: